Higher levels of prorenin predict development of diabetic retinopathy in patients with type 2 diabetes

被引:14
作者
Yokota, Harumasa [1 ]
Nagaoka, Taiji [1 ]
Tani, Tomofumi [1 ]
Takahashi, Atsushi [1 ]
Sato, Eiichi [1 ]
Kato, Yuji [1 ]
Yoshida, Akitoshi [1 ]
机构
[1] Asahikawa Med Coll, Dept Ophthalmol, Asahikawa, Hokkaido 0788510, Japan
关键词
Diabetic retinopathy; prorenin; renin-angiotensin system; type; 2; diabetes; RENIN-ANGIOTENSIN SYSTEM; II RECEPTOR ANTAGONIST; MICROVASCULAR COMPLICATIONS; RETINAL NEOVASCULARIZATION; NONPROTEOLYTIC ACTIVATION; SIGNAL-TRANSDUCTION; (PRO)RENIN RECEPTOR; KINETIC ASSAY; CANDESARTAN; PROGRESSION;
D O I
10.1177/1470320310391327
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The aim was to determine whether serum prorenin levels affect the development of diabetic retinopathy (DR) in type 2 diabetes. Baseline serum prorenin levels were measured in 196 patients (85 males, 111 females) with type 2 diabetes without DR using the antibody-activating direct prorenin assay. The fundi were checked regularly. The participants were divided into two groups based on the serum prorenin levels (high and low). We used Kaplan-Meyer analysis to detect differences in the development of DR between the two groups within the same gender. Kaplan-Meyer analysis showed that males with a high serum prorenin level tended to develop DR earlier and more frequently than males with a low prorenin level (p = 0.004 by the log rank test). However, there was no difference in the development of DR between high and low groups in females (p = 0.58). Serum prorenin levels in males with type 2 diabetes could be a new prognostic indicator of the development of DR.
引用
收藏
页码:290 / 294
页数:5
相关论文
empty
未找到相关数据